作者:
关键词
ANG-CLP, angiopep-2 modified cationic liposomeCMC, critical micelle concentrationCPLA, cationic polylactideChemotherapeutic drugCo-deliveryDOTAP, 1,2-dioleoyl-3-trimethylammonium-propaneDendrimerFA, folic acidFCAP, ferrocenium capped amphiphilic pillar[5]areneGSH, glutathioneGeneLiposomeMicelleNanocarrierOEI, oligoethyleniminePAMAM, poly(amido amine)PAsp(AED), poly(N-(2,2?-dithiobis(ethylamine))aspartamide)PCL, poly(ε-caprolactone)PDMAEMA, polydimethylaminoethyl methacrylatePDPA, poly(2-(diisopropyl amino)ethyl methacrylate)PEG, polyethyleneglycolPEI, poly(ethyleneimine)PEI-Fc, ferrocene modified poly(ethyleneimine)PEI-PCHLG, poly(ethylene imine)-poly(γ-cholesterol-l-glutamate)PEI-PCL, poly(ethyleneimine) and poly(ε-caprolactone)PLA, polylactic acid (or polylactide)PLGA, poly(lactic-co-glycolic acid)PPEEA, poly(2-aminoethyl ethylene phosphate)PnBA, poly(n-butyl acrylate)RNAi, RNA interferenceSNPs, supramolecular nanoparticlesSSTRs, somatostatin receptors poly(N-(2,2′-dithiobis(ethylamine))aspartamide)Supramolecular systemmiRNA, micro-RNAsiRNA, small interfering RNAsiVEGF, VEGF-targeted siRNAγ-CD, γ-cyclodextrin
DOI
10.1016/j.apsb.2015.03.001
PMID
26579443
发布时间
2020-12-26
- 浏览38

Acta pharmaceutica Sinica. B
2015年5卷3期
169-75页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文